New challenges in the management of prolonged survivors of pediatric neuromuscular diseases: A pulmonologist's perspective

Pediatric Pulmonology

Volumn 41, Issue 12, 2006, Pages 1113-1117

  Birnkrant, David J ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Duchenne muscular dystrophy; Neuromuscular diseases; Noninvasive ventilation; Quality of life; Survival

Indexed keywords

DUCHENNE MUSCULAR DYSTROPHY; ETHICS; HEALTH CARE PLANNING; HUMAN; INTENSIVE CARE; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOCIAL ASPECT;

EID: 33845442767     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20515     Document Type: Review

References (24)

1. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: Improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002;12:926-929.
2. Jeppesen J, Green A, Steffensen BF, Rahbek J. The Duchenne muscular dystrophy population in Denmark, 1977-2001: Prevalence, incidence, and survival in relation to the introduction of ventilator use. Neuromuscul Disord 2003;13:804-812.
3. Calvert LK, McKeever TM, Kinnear WJ, Britton JR. Trends in survival from muscular dystrophy in England and Wales and impact on respiratory services. Respir Med 2006;100:1058-1063.
4. Finder JD, Birnkrant D, Carl J, Farber HJ, Gozal D, Iannaccone ST, Kovesi T, Kravitz RM, Panitch H, Schramm C, Schroth M, Sharma G, Sievers L, Silvestri JM, Sterni L. Respiratory care of the patient with Duchenne muscular dystrophy: An ATS consensus statement. Am J Respir Crit Care Med 2004;170:456-465.
5. Wallgren-Pettersson C, Bushby K, Mellies U, Simonds A. 117th ENMC workshop: Ventilatory support in congenital neuromuscular disorders-Congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II). Neuromuscul Disord 2004;14:56-69.
6. Gomez-Merino E, Bach JR. Duchenne muscular dystrophy: Prolongation of life by noninvasive ventilation and mechanically assisted cough. Am J Phys Med Rehabil 2002;81:411-415.
7. Simonds AK, Muntoni F, Heather S, Fielding S. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax 1998;53:949-952.
8. Gripe LH, Klitnzer TTS, Beekman RH, Galioto FM, Jones TK, Manning PB, Morrow WR, Newburger J, Moore JWM. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics 2005;116:1569-1573.
9. Biggar WD, Harris VA, Eliasoph L, Alman B. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord 2006;16:249-255.
10. Bach JR, Sabharwal S. High pulmonary risk scoliosis surgery: Role of noninvasive ventilation and related techniques. J Spinal Disord Tech 2005;18:527-530.
11. Wazeka AN, DiMaio MF, Boachie-Adjei O. Outcome of pediatric patients with severe restrictive lung disease following reconstructive spine surgery. Spine 2004;29:528-534.
12. Birnkrant DJ, Ferguson RD, Martin JE, Gordon GJ. Noninvasive ventilation during gastrostomy tube placement in patients with severe Duchenne muscular dystrophy: Case reports and review of the literature. Pediatr Pulmonol 2006;41:188-193.
13. Phillips MF, Quinlivan RC, Edwards RH, Calverley PM. Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med 2001;164:2191-2194.
14. Birnkrant DJ, Petelenz KM, Ferguson RD, Martin JE, Gordon GJ. Use of the laryngeal mask airway to provide respiratory support during anesthesia or sedation in severe muscular dystrophy. Pediatr Pulmonol, in press. DOI 10.1002/ppul/20497.
15. Bach JR, Baird JS, Plosky D, Navado J, Weaver B. Spinal muscular atrophy type 1: Management and outcomes. Pediatr Pulmonol 2002;34:16-22.
16. Bach JR, Vega J, Majors J, Friedman A. Spinal muscular atrophy type 1 quality of life. Am J Phys Med Rehabil 2003;82:137-142.
17. Rahbek J, Werge B, Madsen A, Marquardt J, Steffenson BF, Jeppesen J. Adult life with Duchenne muscular dystrophy: Observations among an emerging and unforeseen patient population. Pediatr Rehabil 2005;8:17-28.
18. Kennedy JD, Staples AJ, Brook PD, Parsons DW, Sutherland AD, Martin AJ, Stern LM, Foster BK. Effect of spinal surgery on lung function in Duchenne muscular dystrophy. Thorax 1995;50:1173-1178.
19. Kinali M, Messina S, Mercuri E, Lehovsky J, Edge G, Manzur A, Muntoni F. Management of scoliosis in Duchenne muscular dystrophy: A large 10-year retrospective study. Dev Med Child Neurol 2006;48:513-518.
20. Simonds AK. Home ventilation. Eur Respir J 2003;22:38s-46s.
21. Simonds AK. Ethical aspects of home long term ventilation in children with neuromuscular disease. Paediatr Respir Rev 2005;6:209-214.
22. Graham RJ, Dumas HM, O'Brien JE, Burns JP. Congenital neurodevelopmental diagnoses and an intensive care unit: Defining a population. Pediatr Crit Care Med 2004;5:321-328.
23. Yates K, Festa M, Gillis J, Waters K, North K. Outcome of children with neuromuscular disease admitted to the paediatric intensive care unit. Arch Dis Child 2004;89:170-175.
24. Truog RD, Brock DW, Cook DJ, Danis M, Luce JM, Rubenfeld GD, Levy MM; for the Task Force on Values, Ethics, and Rationing in the Critical Care Unit (VERICC). Rationing in the intensive care unit. Crit Care Med 2006;34:958-963.